Omega Therapeutics Corp - OMGA Quarterly EPS earnings growth
Omega Therapeutics is developing an epigenome management system to correct genetic defects. Quarterly earnings per share growth confirms this trend, where the value of 0.00 characterizes this level. Revenues are based on the creation of mRNA drugs for cancer therapy. Research stability is ensured by a neutral geopolitical status and the protected nature of the US healthcare sector.
%20Year-over-year%20earnings%20per%20one%20share%20growth%20for%20the%20last%2012%20months&width=1200&height=400&colorIndex=0&v=mwg3sw3k.w4s-7di3ke8&start=20220704&end=20261114&filename=GURU_Markets_-_OMGA_-_Omega-Therapeutics_-_Year-over-year-earnings-per-one-share-growth-for-the-last-12-months "Omega - OMGA Quarterly EPS earnings growth (period 07/04/2022 - 03/08/2025) | 👁️GURU.Markets👁️")
OMGA (omegatherapeutics.com): analytical breakdowns and indicator data
- share price and consensus valuation forecast:
- issuer market value details:
- balance sheet net asset value indicators:
- business debt structure and liquidity details:
Total Debt to Capital Omega Therapeutics|OMGA - Long-Term Debt to Capital|Short-Term Debt to Equity Omega Therapeutics|OMGA - Company Aggregate Indebtedness|Debts to Book Capitalization Omega|OMGA - Long-Term Debt|Company Current Liabilities Omega Therapeutics|Quick Liquidity Indicator omegatherapeutics.com
- earnings and valuation multiples indicators:
OMGA - Profit After Payment of Taxes|Projected Future Earnings Omega Therapeutics|OMGA - Business Payback Period|Forward P/E Multiple omegatherapeutics.com|OMGA - Price/Earnings to Growth Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Omega Therapeutics Inc|OMGA - Operating income before deduction of amortization|Earnings per share for the last twelve months Omega Therapeutics|OMGA - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months omegatherapeutics.com|OMGA - Net earnings per share growth this year|Earnings growth forecast for next year Omega Therapeutics
- sales volume and revenue indicators:
General company analysis:omegatherapeutics.com - OMGA
Since Omega Therapeutics (OMGA) is in the early research stages of programmable mRNA and has no revenue streams, its financial position is determined exclusively by capital expenditure. Quarterly EPS variability reflects the rate of change in net income per share, allowing investors to assess the impact of macroeconomic factors and the cash burn rate through the lens of the market value of each share.
Analysis of competing companies
TEM: Quarterly EPS earnings growth|Qiagen Corp - Year-over-year earnings per one share growth for the last 12 months|IONS (Ionis Pharmaceuticals) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months RGEN (Repligen)|Quarterly EPS earnings growth RNA|CRSP (CRISPR Therapeutics) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth WGS (GeneDx Holdings Corp.)|RARE: Year-over-year earnings per share growth for the last 12 months|BEAM - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months sarepta.com|TWST: Quarterly EPS earnings growth|TXG - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Intellia|Earnings per share growth in annualized terms for the last twelve months Stoke Therapeutics STOK|Quarterly EPS earnings growth BLFS|Wave Life Sciences - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth MAZE (Maze Therapeutics, Inc.)|Quarterly EPS earnings growth Sionna Pharma SION|Prime Medicine Bio - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months TSHA (Taysha)|QURE: Quarterly EPS earnings growth|MGTX - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months RGNX|SLDB: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months ocugen.com (OCGN)|Year-over-year net earnings per share change for the last twelve months PacBio Corp|Year-over-year earnings per share growth for the last twelve months Benitec Biopharma BNTC|DSGN: Year-over-year earnings per share growth for the last 12 months|RCKT - Year-over-year earnings per share growth for the last twelve months|4dmoleculartherapeutics.com (FDMT) - Year-over-year net earnings per share growth for the last 12 months|lexeotx.com (LXEO) - Year-over-year earnings per share growth for the last twelve months|Korro Bio, Inc (KRRO) - Quarterly EPS earnings growth|EDIT (editasmedicine.com) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months SLN (silence-therapeutics.com)|Year-over-year earnings per share growth for the last twelve months proqr.com (PRQR)|Codexis - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth SGMO (Sangamo Therapeutics)|Quarterly EPS earnings growth nautilus.bio NAUT|Metagenomi Inc. - Quarterly EPS earnings growth|DTIL (Precision BioSciences Inc.) - Year-over-year earnings per share growth for the last 12 months|GBIO: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Boundless Bio, Inc (BOLD)|XCUR (Exicure) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Imunon (IMNN)|Quarterly EPS earnings growth PHIO|Mustang Bio - Year-over-year earnings per share growth for the last 12 months|TransCode Therapeutics, Inc. - Year-over-year net earnings per share growth for the last 12 months|Year-over-year net earnings per share change for the last twelve months Bionano Genomics, Inc. (BNGO)|APDN - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months BLUE (Bluebird Bio)|ImmunoPrecise (IPA) - Year-over-year earnings per share growth for the last twelve months|singulargenomics.com (OMIC) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months RGLS|Syros (SYRS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months telesisbio.com (TBIO)|TCON - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth UBX (Unity Biotechnology Inc.)
